Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes by unknown
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Fibronectin (Fn) 1 is a 440,000-dalton glycoprotein found in plasma at a concentra- 
tion of -300/~g/ml  (1).  The structure of the molecule has been carefully examined, 
and domains that bind gelatin, heparin, and Staphylococcus aureus have been described 
(2).  Fibronectin also mediates the binding of gelatin-coated particles to Kupffer cells 
in vivo and in vitro (3), and it has been alleged to be an important component in the 
optimal function of the reticuloendothelial system (RES)  (4). However, the role of Fn 
in normal host phagocytic function remains unclear. While some investigators have 
gathered evidence that Fn is an opsonin (5, 6), others have been unable to show that 
Fn-coated particles will be phagoeytosed (7, 8). In the experiments reported here, we 
have discovered that  Fn  binding  to  particles  is  not  required  for Fn  to  affect their 
ingestion by human peripheral blood monocytes. Fn enables monocytes to phagocy- 
tose  erythrocytes  bearing  C3b  molecules  and  increases  the  phagocytosis  of  IgG- 
sensitized erythrocytes without binding to the opsonized particles. Thus, Fn may be 
important  in  host  defense  in  the  development  and  maintenance  of an  optimally 
phagocytic state in the mononuclear phagocytes of the RES. 
Materials and Methods 
Buffers.  Isotonic Veronal-buffered saline  (VBS),  VBS containing 0.1% gelatin, 0.15  mM 
Ca  ++, and  1 mM Mg  ++ (GVB++), low ionic  strength isosmotic  Veronal-buffered saline with 
dextrose,  gelatin, Ca  ++, and Mg  ++ (DGVB), and VBS containing gelatin and  10 mM ethyl- 
enediaminetetraacetate  (EDTA-GVB) were all prepared as previously described  (9). RPMI 
1640 was obtained from the Media Unit, National Institutes of Health. 
Purification of Fn.  Human  plasma Fn  was purified  by a  modification of the  method of 
Vuento  and Vaheri  (10). Briefly,  1 U  of plasma was diluted  while stirred with a  buffered 
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inhibitor solution containing 1 M  KH2PO4, 0.2 M  Na2EDTA, and 0.2 M  benzamidine HC1, 
pH 7.4 (20 parts plasma to 1 part inhibitor). Phenylmethyl sulfonyl fluoride (PMSF) was then 
added to a final concentration of 1 raM. The inhibitor-treated plasma was then made 5% wt/ 
vol  in  polyethylene glycol 3350  (PEG)  (J.T.  Baker Chemical  Co.,  Phillipsburg, NJ).  The 
precipitate that formed after 1 h at 4°C was resuspended in 150 mM NaC1, 50 mM KH2PO4/ 
K2HPO,, and  10 mM EDTA, pH 7.4,  and snap frozen by adding approximate 20-/zl drops 
directly  to  liquid  N~.  The  pellets  thus  formed  were  stored  at  -70°C  until  further  use. 
Approximate 15-ml aliquots of this 5% PEG precipitate were thawed and passed over a  5-ml 
column of Sepharose 4B. The protein-containing fractions were pooled and passed over gelatin- 
Sepharose prepared as described (10). The column was then thoroughly washed and eluted as 
described. The  protein-containing fractions were  pooled, dialyzed vs.  0.05  M  Tris-HC1  to 
remove arginine, centrifuged for 20 rain at 12,000 g, and passed over arginine-Sepharose. The 
retained material was eluted with a buffer of 0.1 M  NaC1, 0.05 M Tris, pH 7.5. All buffers used 
for the chromatography on Sepharose, gelatin-Sepharose, and arginine-Sepharose contained 5 
mM  benzamidine  and/or  1  mM  PMSF  to  inhibit  the  possible activity of contaminating 
proteases on Fn. The purified Fn showed a single line on immunoelectrophoresis vs. anti-whole 
human serum and a single major band at 440,000 dahons on sodium dodecyl sulfate-polyacryl- 
amide gel electrophoresis (SDS-PAGE). Overloaded gels showed trace bands at 210,000 dahons 
and 230,000 daltons as well as the 440,000-dalton protein. On reduction of disulfide bonds, a 
closely spaced doublet was seen at 220,000 daltons as has been previously reported for human 
plasma Fn (1, 2). With increased sample size, the doublet was obliterated, but these heavily 
loaded gels showed no lower molecular weight bands even when developed with a  sensitive 
silver stain (Bio-Rad Laboratories, Richmond, CA)  (Fig,  1). Antibody prepared against this 
antigen in a rabbit gave a monospecific response on immunoelectrophoresis and Ouchterlony 
double diffusion against whole human plasma. 
Monocyte Preparation.  Peripheral blood mononuclear cell.s were separated from the buffy coat 
from  500  ml  of blood of normal volunteers on  Ficoll-Hypaque gradients.  Monocytes were 
isolated using a J2-21 centrifuge (Beckman Instruments, Palo Alto, CA) equipped with a JE-6 
elutriator rotor with two Sanderson's separation chambers following a procedure modified from 
Lionetti et al. (11). The purity of the monocytes was >95% as determined by both morphology 
and nonspecific esterase staining (Technicon Instruments Corp., Tarrytown, NY). 
Antibody and Complement Components.  C1, C4, and C2 were purchased from Cordis Laborato- 
ries Inc., Miami, FL. Rabbit IgG and IgM anti-Forssman (12) and human C3 were prepared 
as previously described (13).  C3b was prepared by trypsin incubation of purified C3 followed 
by Biogel A 0.5-m chromatography as previously described (14). 
Opsonized Sheep Erythrocytes.  Sheep erythrocytes (E) were collected, washed, and stored using 
standard methods (12). For preparation of C3b-opsonized particles, E were sensitized with IgM 
anti-Forssman antibody (EAxgM);  C1, C4, C2, and C3 were then added sequentially as previously 
described (15). The concentration of C4 was limited to prevent interaction of EAIgM C14 with 
C3b receptors. EAI~ C14 were incubated with 5 U  of C3 to yield 100-200 C3 molecules per 
cell. Following sensitization with C3, EAIgM C1423b were incubated for 1 h in EDTA-GVB to 
remove C 1 and to allow C2 to decay, and then washed twice in GVB  ++  (EAIgM C43b).  For 
preparation of EAI,o, 1 ×  l0  s E/ml were incubated for 30 min at 37°C with a  1:2,000-dilution 
of IgG anti-Forssman antibody. The cells were then washed twice in GVB  ÷+ (EA~). 
Rosetting and Phagocytosis Assay.  For assay of leukocytes in suspension, 50/zl of cells at 2 × 
108/ml in RPMI  1640, supplemented with 5 mM MgCI2, were incubated for 30 min in a  5% 
CO2/95%  air incubator at  37°C  with Fn or as a  control, Fn passed over gelatin-Sepharose 
immediately before the experiment. Except where noted, the cells were then mixed with 50/zl 
of EAIgM C43b, or EA~,o at 1.5 ×  l0  s E/ml without washing. The cells and indicator particles 
were sedimented by centrifugation for 5 min at 50 g, incubated for a  further 30 min in a  5% 
CO2/95% air incubator at 37°C without mixing, and then gently resuspended and examined 
under light microscopy. In assays of monocyte monolayers, monocytes were suspended at 2 × 
10  ~ cells/ml in RPMI  1640 without added protein; 250/~1 was added to each chamber of an 
eight-chamber tissue culture plate (Lab-Tek Div. Miles Laboratories Inc., Naperville, IL); and 
the cells were  allowed to adhere to  glass during  a  45-min  incubation  in  a  5%  CO2,  37°C 
incubator. The cells were then washed in RPMI 1640. Various concentrations of Fn, buffer, or 1846  FIBRONECTIN  ENHANCES PHAGOCYTOSIS  BY  MONOCYTES 
FIo.  1.  SDS-PAGE of purified fibronectin (fn). 5 ~g of the purified Fn preparation was electro- 
phoresed in 4-10% SDS-PAGE gels both in the presence  (/eft lane) or the absence  (middle lane) orS0 
mM dithiothreitol. The right lane contains Bio-Rad high molecular weight standards  (myosin, Mr 
200,000;  fl-galactosidase,  Mr  130,000;  phosphorylase  B,  Mr  93,000; bovine serum  albumin;  Mr 
68,000;  and ovalbumin, Mr 43,000).  After eleetrophoresis,  the gel was  stained  with the Bio-Rad 
silver stain. 
the supernatant  of an absorption of the Fn preparation with gelatin-Sepharose  (done immedi- 
ately before the experiment) were added to the cells, and incubation was allowed to proceed for 
a  further  30  min.  After incubation,  indicator  particles  were  added  to  the  wells,  the  plates 
centrifuged at  50 g  for 5  rain,  and  an  additional  incubation  was carried out as described  for 
fluid  phase  cells.  After this  incubation,  chambers  were  washed  two  times,  fixed  with  0.5% 
glutaraldehyde, and stained with Giemsa stain. To quantitate phagocytosis, assays were carried 
out  exactly  as  described,  except  that  an  erythrocyte  lysis  step  0aypotonic  lysis,  in  1  part 
phosphate-buffered  saline  [PBS]  and  4  parts  HzO, with  vigorous mixing for several seconds) 
was added before fixing, staining, and counting. In all experiments, at least 200 leukocytes were 
counted to quantitate erythrocyte rosetting and/or ingestion. Three or more erythrocytes bound 
to  a  leukocyte was  considered  a  rosette.  Total  intracellular  erythrocytes  were counted  as  a 
function of the number of monocytes observed. 
Preincubation  of Monocytes  or Indicator  Particles  with  Fn.  In some experiments,  monocytes or 
EAI~ C43b were incubated with Fn and washed before mixing for assays of particle ingestion. 
For  these  studies,  fluid  phase  monocytes  were  incubated  for 30  rain  at  37°C  with  varying 
concentrations  of Fn in RPMI/Mg ++ buffer or with buffer alone and  then  washed  in warm 
buffer.  This  wash  removed  >95%  of the  Fn  as  determined  by  inclusion  of  125I-Fn in  "the POMMIER  ET AL.  1847 
incubation mixture. Thereafter, monocytes and EAI~ C43b, which had been incubated with 
buffer, were mixed, and ingestion was quantitated as described. Parallel sets of experiments 
were  performed  in which  EAtl~t  C43b  were  preincubated with  Fn and  then  mixed with 
monocytes which had been incubated in buffer. 
Determination of Fc Receptor Number.  The binding of 125I-labeled monomeric myeloma IgG 1 
was used to determine the number of IgG receptors present on monocytes before and after 
incubation with  Fn.  For  these  experiments, monocytes were  incubated with  RPMI  1640 
supplemented with 5 mM MgClz or this buffer containing 20 #g/ml Fn for 30 min at 37°C 
before performance of the binding studies, which were then carried out exactly as previously 
described (16), 
Results 
Effect of Fn on Monocyte Rosetting and Ingestion of EA~  The ability of fluid phase Fn 
to  affect  monocyte rosetting and ingestion of EAigo was examined. In preliminary 
experiments, IgG anti-Forssman was titrated so that in the absence of Fn, rosetting 
was less than maximum. Incubation of monocytes with Fn in concentrations of 40- 
160/~g/ml caused a  modest increase in the number of monocyte rosettes. Fn caused 
a  dose-related increase in rosetting for both  fluid phase and monolayer monocytes 
from  13% to a  maximum of 55%.  Monoeytes did not form rosettes with E  or EAI~ 
with or without Fn. 
Fibronectin  caused a marked increase in the number of EAi~ ingested by monocytes 
(Fig. 2A), As with rosetting, Fn caused a  dose-related increase in ingestion for both 
fluid  phase  and  monolayer monocytes.  For  fluid phase  monocytes the  number of 
EAIgG ingested increased from  113  :t:  15.9 to 250 +  44.4 with  160/~g Fn/ml  (P < 
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Fro.  2.  The effect of fibronectin (Fn) on monocyte phagocytosis. In A the phagocytosis of EA~ 
by fluid phase (1) and glass adherent (I[]) monocytes  is shown as a function of Fn concentration. E 
(A) and EA~ (A) are not ingested by monocytes in the presence or absence of Fn. In B the same 
data are shown for the ingestion of EA~ C43b. EA~M (A) and EAIsM C4 (&) are not ingested. 
When the number of monocytes ingesting EAx~ is compared for 0 and 160/zg/ml Fn, the increase 
is only from 48% to 61%. (Inset) Most of the increased phagocytosis occurs because of increased 
ingestion by a subpopulation of the monocytes. 1848  FIBRONECTIN ENHANCES PHAGOCYTOSIS BY MONOCYTES 
0.001). For monolayer monocytes, a plateau was reached at a lower concentration of 
Fn than for fluid phase monocytes with a maximum of 296 :t: 24.5 EAIgo ingested per 
100 monocytes at 40/~g/ml Fn. When the percentage of monocytes ingesting EAI~ 
was quantitated with and without Fn, only a  small increase, from 48% to 61%, was 
observed (Fig. 2, inset). Thus, most of the increased ingestion of the antibody-sensitized 
erythrocytes resulted from more avid phagocytosis by a portion of the monocytes in 
the presence of Fn. As was the case in every experiment, gelatin-Sepharose absorption 
of the Fn abolished its effect on monocyte phagocytosis of EAIgo. When fluid phase 
monocytes were incubated  under  identical conditions with  equivalent  amounts  of 
C3b, human serum albumin  (HSA), and Fn, Fn caused a  twofold increase in total 
ingestion of EAts; neither HSA nor C3b affected the ability of monocytes to bind or 
ingest EAI~. 
Effect of Fn on Monocyte Rosetting and Ingestion of EAIgM C43b.  The effect of Fn on 
rosette formation and  ingestion  by monocytes with  EAI~  C43b  was  examined in 
experiments analogous to those performed with EAI~.  As in the case of IgG, a  C3 
input  was chosen in the preparation of EAxgM C43b that was  less  than that which 
would produce optimal rosetting with monocytes. Fn caused a  dose-related increase 
in the percentage of monocytes forming rosettes from  15% to 32% with fluid phase 
monocytes, and  from  18%  to 40% with monolayer monocytes. No  phagocytosis of 
these E bearing C3b as the only opsonin was seen in the absence of Fn for either fluid 
phase  or  monolayer monocytes.  The  inability of monocytes to  ingest  C3b-coated 
erythrocytes in  these experiments is  in  agreement with  previous observations  (17). 
However, incubation of monocytes with Fn  led to phagocytosis of EAIgM C43b  by 
both fluid phase and monolayer cells. The extent of ingestion was dependent on the 
Fn  input  (Fig.  2B).  As  had  been  observed  with  EAtgG ingestion,  C3b-mediated 
ingestion by Fn-treated monocytes was quantitatively greater for monolayer mono- 
cytes, and the Fn close response reached a plateau at lower concentrations of Fn. For 
both EAIgo and EAIgM C43b, addition of 0.1% gelatin to the buffer did not affect the 
Fn enhancement of phagocytosis. 
To  examine  whether  Fn  was  interacting  with  the  monocyte or  the  opsonized 
particle to cause ingestion, Fn was preincubated with EAIgM C43b or with monocytes 
alone and removed by washing as described in Materials and Methods. Complement- 
sensitized erythrocytes that  had  been preincubated with  varying doses of Fn were 
mixed with monocytes that had been incubated in buffer. In other tubes, monocytes 
that  had  been preincubated with  Fn were mixed with EAigu C43b that  had  been 
incubated in buffer. As a  positive control, some monocytes were incubated with Fn, 
and indicator particles were added without washing, exactly as in the usual protocol. 
The results are shown in Fig. 3. Phagocytosis of EAIgM C43b occurred when monocytes 
were preincubated with  Fn  or when  Fn was  present  throughout  the  assay.  Signif- 
icantly, no phagocytosis occurred when only EAIgM C43b had been incubated with 
Fn. Thus, a direct interaction of Fn with monocytes, but not with opsonized particles, 
was required for ingestion of EAIgM C43b. 
Several experiments were performed to ensure that the biologic activity of the Fn 
preparation on monocytes was not caused by a trace contaminant in the preparation. 
The ability of gelatin-Sepharose to remove the phagocytosis-promoting activity from 
Fn preparations was examined and compared to protein-A Sepharose (because IgG 
may be a  contaminant of Fn preparations  [18])  (Table I). Absorption with  1 ml of POMMIER  ET  AL.  1849 
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FIG. 3.  Preincubatlon of monocytes and target cells with fibronectin (Fn). Fluid phase monocytes 
(A) or EAtgM C43b (&) were incubated with Fn for 30 rain at 37°C, washed, and then mixed with 
buffer-incubated EAIsM C43b or monocytes.  As a positive control monocytes were incubated with 
Fn and then with EA~M C43b without washing (Q). Phagocytosis  is plotted as a  function of Fn 
concentration. Only when monocytes were exposed to Fn does erythrophagocytosis  occur. 
TA~X.E  I 
Effect of Affinity Absorption on the Phagocytosis-Enhancing Effect of 
Absorption 
Fibronectin (Fn)* 
Erythrocytes ingested/100 
monocytes 
EAr~  EAtc~t e4~b 
None  203  69 
Sepharose 4B-CL  210  ND* 
Protein A-Sepharose  215  72 
Gelatin Sepharose  106  0 
No Fn added  114  0 
* 200-#g aliquots of Fn, purified as described, were incubated with  1 ml of 
Sepharose 4B-CL, with protein A Sepharose, or with gelatin Sepharose. The 
absorbed supernatant was then assayed for phagocytosis-promoting  activity 
using  EAx~  or  EA~M  c4sb. Gelatin-Sepharose absorbed  all  phagocytosis 
promoting activity, but  protein A  Sepharose or Sepharose alone did not 
affect the biologic activity of the Fn preparation. 
* ND, not done. 
gelatin-Sepharose entirely removed the phagocytosis-promoting activity of 200 #g of 
the Fn preparation for EAIgG, but the activity was unaffected by passage over similar 
amounts of protein-A Sepharose or Sepharose 4B-CI alone. In fact, supernatants from 
gelatin-Sepharose-absorbed  Fn  were  routinely  used  as  a  negative  control  in  all 
experiments on Fn-enhanced phagocytosis of EAI~ and EAIgM C43b;  rosetting and 
ingestion in these tubes never exceeded binding and phagocytosis in tubes containing 
buffer alone. 
Because of a  report that the phagocytosis-enhancing effect of Fn preparations for 
alternative pathway activators resides in a  180,000-dalton co-purifying protein  (19- 
21), our Fn preparation was chromatographed on a calibrated Biogel A 1.5-M column 
(Fig.  4).  If the phagocytosis-promoting activity were  smaller than the  Fn protein, 
fractions lighter than the main protein peak should have contained biologic activity. 
However, the biologic activity of the preparation exactly co-chromatographed with 
the 440,000-dalton protein peak. 
Because many investigators use 4 M  urea to elute Fn from gelatin Sepharose (1), 1850 
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FIo.  4.  Biogel A  1.5m chromatography of purified fibronectin (Fn) and ofphagocytosis-promoting 
activity. Fn, purifed as in Materials and Methods, was chromatographed on a calibrated Biogel A 
1.5m column. Fractions were assayed for protein concentration by absorbance at 280 nm (0) and 
for phagocytosis-promoting activity by ingestion of EAI~ after incubation of 1 ×  i0  s monocytes 
with 50 #1 of the various column fractions (&). The phagocytosis-enhancing activity coincides with 
the Fn protein peak. 
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Fro.  5.  Binding of IgO to monocytes, x25I-IgO binding was assessed to monocytes which had been 
incubated  in  buffer  (0)  or  with  20 #g/ml  Fn  (A).  The binding curves for  the  Fn-  and  buffer- 
incubated cells overlie one another. Scatchard transformations of the binding curves show that the 
control cells showed an average of 28,700 IgO-binding sites per cell with Ka =  4.03 X  10  s M-l~ while 
Fn-incubated cells showed 31,900 Ig~ binding sites per cell with KI =  3.57 X  10  s M -1. These values 
for Fn- and buffer-incubated cells are not statistically significantly different. 
this  procedure  was  used  to  purify  Fn,  and  the  eluted  material  was  examined  for 
biologic activity. Although slightly less effective on a weight basis than Fn purified as 
described  above,  this  urea-eluted  material  also  promoted  ingestion  of EAI~  and 
EAI~ C43b. POMMIER  ET  AL.  1851 
Enumeration of Fc receptors on Fn-Treated  Monocytes.  To examine the possibility that 
Fn  augmented EAI~  phagocytosis by increasing the expression of Fc receptors on 
monocytes, Fc receptors were enumerated in a well-characterized quantitative assay 
for the binding of monomeric monoclonal IgG1  (Fig. 5). Monocytes that had been 
incubated with 20 #g/ml Fn for 30 min at 37°C showed no difference in IgG receptor 
number (30 ×  10S/cell) or affinity (3.8 ×  l0  s M -x) compared to monocytes incubated 
with buffer. 
Discussion 
In 1969 Saba and DiLuzio (22) suggested that depletion of a plasma protein could 
be  responsible  for RES  dysfunction  in  experimental  RES  blockade.  This  opsonie 
protein could mediate the binding of gelatin-coated particles to Kupffer cells in vivo 
and in vitro (23). Subsequent work from several laboratories showed that this protein, 
a2 opsonic surface-binding glycoprotein, was identical to cold insoluble globulin, or 
Fn  (4).  Recent  work  by Bevilacqua et  al.  (8)  demonstrated  a  receptor for Fn  on 
human  monocytes.  Taken  together,  these  data  suggested  that  Fn  might  play  an 
important role in monocyte and macrophage phagocytosis. Our initial experiments 
using E  showed that Fn could markedly affect monocyte binding and phagocytosis 
but only when the erythrocytes were already opsonized. This suggested that Fn acted 
directly on the monocyte without binding to the phagocytic target, unlike conven- 
tional opsonins such as IgG or complement. In support of this hypothesis we found 
that incubation of erythrocyte targets with Fn had no effect on subsequent monocyte 
phagocytosis. 
The process of particle phagocytosis may be divided into phases of adherence and 
ingestion.  In  our  experiments,  adherence  of both  IgG-  and  C3b-opsonized  E  to 
monocytes was somewhat increased by Fn, which was in agreement with the work of 
Bevilacqua et al. The more marked effect in our experiments, however, was on the 
ingestion of opsonized particles.  This was  particularly true for EAt~ C43b, which 
were not  ingested in the absence of Fn, but whicb were phagocytosed to the same 
extent as EAI~ when Fn was present during the incubation. Although this increase 
in phagocytosis was not found by Bevilacqua et al., the complement-coated particles 
used in their experiments were less well characterized than in ours since they used 
mouse serum rather than  purified human  components as a  source of complement. 
Under the conditions of incubation, it is probable that most of the C3 on their cells 
was in the form of C3bi or C3d, rather than C3b. 
A  number of experiments were done to examine whether the biologically active 
molecule  in  our  Fn  preparations  was  native  Fn.  Great  care  was  taken  during 
purification of the  Fn,  particularly during plasma  collection, to  inhibit  enzymatic 
degradation of native Fn. The use of denaturing buffers containing urea or guanidine 
was deliberately avoided in order to attempt to preserve the native configuration of 
plasma Fn. The biological activity of the Fn preparation was not a trace contaminant 
such as endotoxin or IgG since the activity was absorbed by gelatin Sepharose but not 
by protein A-Sepharose. Moreover, the biologic activity co-chromatographed with the 
native protein on a sieving column. These facts led us to conclude that the biologic 
activity resided in the 440,000-dalton native Fn. However, our data do not exclude 
the  possibility  that  the  tertiary  structure  of the  Fn  molecule  is  changed  without 
cleavage during purification or that  a  cleavage is made that  does not significantly 1852  FIBRONECTIN  ENHANCES PHAGOCYTOSIS BY MONOCYTES 
affect the mobility of the molecule on SDS-PAGE or molecular sieving, as has recently 
been suggested (24). 
Several  experiments  were  done  to  characterize  the  mechanism  by  which  Fn 
enhances  phagocytosis.  These experiments showed  that  fluid  phase  Fn  influenced 
monocyte binding and phagocytosis of opsonized particles through interaction with 
the monocyte and did not require the concomitant presence of the phagocytic target 
for its effect. This presumably was mediated via a cell membrane receptor for the Fn 
molecule  (8).  One  possible  explanation  for  the  mechanism  of the  Fn  effect  on 
monocytes is that incubation with Fn increases the membrane expression of Fc and 
C3b  receptors. This hypothesis was  tested in  an experiment in which Fc receptors 
were enumerated, and their affinity measured, on monocytes with and without Fn 
preincubation. Fn had no effect on the number or affinity of monocyte receptors for 
monomeric IgG. Thus, by this assay, membrane expression of phagocytic receptors 
was not changed by Fn incubation. Although Fn incubation did increase the number 
of rosettes formed with EAI~, monocyte Fc receptor number does not correlate well 
with rosette formation (Fries, L., S. Inada and M. Frank, unpublished data). Griffin 
et al. (25) have presented evidence that a lymphokine causes ingestion of  complement- 
coated erythrocytes by increasing the mobility of the C3 receptor in the macrophage 
membrane. It is tempting to speculate that this may also be the mechanism of action 
of Fn.  Increased  Fc  and  C3b  receptor mobility in  the  monocyte membrane  after 
incubation  with  Fn  could explain  both  the observed increase in  rosetting without 
increase in  Fc receptor number and  the increased ingestion of opsonized particles. 
Details of the mechanism  by which Fn affects monocyte membranes  await  further 
study. 
Summary 
We have investigated the effect of plasma fibronectin (Fn) on binding and phago- 
cytosis of sheep erythrocytes (E) by human peripheral blood monocytes. Unopsonized 
E  were not  phagocytosed in  the  absence or presence of Fn,  but  Fn  enhanced  the 
phagocytosis of E bearing IgG. Sheep erythrocytes sensitized with IgM and C3b were 
ingested only when monocytes were exposed to Fn. The Fn enhancement of phago- 
cytosis occurred for both fluid-phase and glass-adherent monocytes. Experiments in 
which Fn was washed out before mixing monoeytes with opsonized E demonstrated 
that  the Fn effect occurred because of interaction with the monocytes and  not  the 
opsonized particles.  Chromatography of the Fn on Biogel A  1.5m showed that  the 
phagocytosis-enhancing activity exactly co-chromatographed with the Fn protein. Fn 
did not increase the number of monocyte membrane receptors for the Fc fragment of 
monomeric  IgG.  We  conclude  that  Fn  enhances  monocyte phagocytosis,  not  by 
binding to particles as a conventional opsonin, but by stimulating monocytes to ingest 
already opsonized particles more avidly. 
The authors wish to thank Karen Leighty for excellent editorial assistance. 
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